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ABSTRACT: An in silico computational technique for
predicting peptide sequences that can be cyclized by
cyanobactin macrocyclases, e.g., PatGmac, is reported. We
demonstrate that the propensity for PatGmac-mediated
cyclization correlates strongly with the free energy of the so-
called pre-cyclization conformation (PCC), which is a fold
where the cyclizing sequence C and N termini are in close
proximity. This conclusion is driven by comparison of the
predictions of boxed molecular dynamics (BXD) with experimental data, which have achieved an accuracy of 84%. A true blind
test rather than training of the model is reported here as the in silico tool was developed before any experimental data was given,
and no parameters of computations were adjusted to ﬁt the data. The success of the blind test provides fundamental
understanding of the molecular mechanism of cyclization by cyanobactin macrocyclases, suggesting that formation of PCC is the
rate-determining step. PCC formation might also play a part in other processes of cyclic peptides production and on the practical
side the suggested tool might become useful for ﬁnding cyclizable peptide sequences in general.
Being able to predict folded shapes and biochemicalproperties of proteins and other biological molecules
simply from their amino-acid sequences is one of the central
problems in computational biochemistry. With the develop-
ment of eﬃcient methods of atomistic simulations, substantial
progress has been made in this direction. For example, fast
protein folding has been accurately simulated by molecular
dynamics (MD).1,2 In general, predicting the properties of
biomolecules solely from their chemical structure remains a
challenge.
In this paper we demonstrate that cyclizable peptide
sequences can be reliably predicted computationally. The
propensity for cyclization correlates with the probability of the
sequence to adopt the so-called pre-cyclization conformation
(PCC) in which its termini are close to each other. The
probabilities of adopting PCC [P(PCC)] have been calculated
with the help of boxed dynamics3−5 for 25 peptides previously
studied experimentally. The calculations performed in the
manner of a blind test, i.e., without prior knowledge of the
experimental data, resulted in an 84% success rate.
Cyclic peptides are attractive scaﬀolds for the pharmaceutical
industry as they are capable of interacting with larger binding
sites than small molecules. They can target protein−protein
interactions (PPis) involved in infections (e.g., gramicidin S)
and diseases such as cancer (e.g., somatostatin) and auto-
immune disorders (e.g., cyclosporine).6,7 Cyclic peptides are
now considered as cheaper and more practical medium-sized
pharmaceutical alternatives to biologics.8−10 Cyclic peptides
have a number of advantages over their linear counterparts,
which include reduced susceptibility to rapid metabolism,
improved membrane permeability, and better binding aﬃnity.11
Unfortunately, the production of cyclic peptides is often
diﬃcult and costly. Most processes rely on the cyclization of a
linear peptide under high dilution conditions to prevent
oligomerization side-reactions. The success of this method is
largely dependent on the sequence and the length of the
peptide, and its viability as a production method has not yet
been proven. Epimerization of the activated residue during
cyclization can present additional diﬃculty.7 An alternative
approach is to carry out cyclization on polymeric support,
which also helps minimize the production of cyclo-oligomers.
This method is complicated as it requires attachment of the
peptide to a solid support via an amino acid side chain and
needs an orthogonal protecting group strategy.12 Another
recent method of peptide cyclization, which has had some
success, relies on incorporation of conformational elements,
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such as proline or pseudoprolines, that help the peptides adopt
the appropriate folded conformations. Other strategies involve
the use of cavities created by polymeric scaﬀolds, or assistance
of the cyclization by metal-ions. Another important biochemical
method makes use of a sortase, but this technique leads to the
incorporation of a LPXTG sequence in the cyclic peptide
product where X is variable.13
Previously, a new biosynthetic approach to making cyclic
peptides in vitro was proposed.14 The new method uses a
macrocyclase, PatGmac, to catalyze N- to C- cyclization, and in
the current paper an in silico tool for ﬁnding peptide sequences
cyclizable by PatGmac will be described.
Mechanism of Cyclization, Experimental Data, and Compu-
tations. PatGmac is an enzyme involved in biosynthesis of the
marine cyclic peptides, patellamides. It is a subtilisin-like
protease, which recognizes a C-terminal three-residue recog-
nition signal (AYD) attached to the core sequence, cleaves it
oﬀ, and cyclizes the substrate. To favor cyclization over
proteolysis, the substrate has to adopt a bent conformation in
which its amino terminus is in close proximity to the enzyme−
substrate acyl complex.15 In this paper, this conformation is
called the pre-cyclized conformation (PCC) (Figure 1).
All cyclizable substrates contain a core sequence ending
either by proline (Pro) or thiazoline (ThH) before the AYD
enzyme recognition signal.16 Structural data and computa-
tions17 shows that the aspartate in the AYD signal binds to the
basic residues Lys594 and Lys598 in the enzyme, preventing
water from attacking the acyl complex. Instead, the free N-
terminal amino group of the peptide substrate attacks the acyl
complex, resulting in cyclization of the core peptide
sequence.15,17 This attack can occur only if the PCC
conformation is adopted. Thus, the formation of PCC may
be the rate-limiting step for cyclization by PatGmac.
Although PatGmac from the patellamide biosynthetic pathway
is the most studied, other homologues were identiﬁed later, e.g.,
LynGmac from an aestuaramide biosynthetic pathway,
18,19 and
assumed to work through the same mechanism.
We have previously developed an approach to simulating
nonenzymatic peptide cyclization5 that successfully reproduced
the kinetics of cyclization and was able to calculate the potential
of the mean force (PMF), which is the free energy as a function
of the distance between two termini. To apply the method-
ology5 to enzymatic cyclization, our working hypothesis here
was that the formation of the PCC (stage c in Figure 1) is the
limiting step of the process, and the enzymatic environment
does not strongly inﬂuence this step. If this is the case, then the
likelihood of cyclization should correlate with the free energy of
the PCC fold when C and N termini of the cyclizing sequence
are close to each other. Only the peptide sequences with low
free energy of PCC and high probability P(PCC) can be
cyclized by PatGmac. The formation of PCC may play an
important part in the processes of cyclization other than by
PatGmac, which makes this study potentially applicable to other
models of peptide macrocyclization.
To test this hypothesis, a data set of 25 peptides of varying
length (5−17 amino acid residues) and containing mainly L
and in some instances 1−3 D-amino acids were prepared by
solid-phase synthesis, and the sequences were conﬁrmed by
liquid chromatography−mass spectrometry LC-MS and MS/
MS analyses (see Supporting Information). Peptides incorpo-
rating thiazoline residues were obtained by treatment of the
cysteine-containing linear peptides by LynD heterocyclase.20
Figure 1. A cartoon showing the steps of cyclization by PatGmac. (a) Binding of the substrate recognition signal AYD to the enzyme. (b) Formation
of the acyl complex with the catalytic Ser783 and proteolytic cleavage of the AYD signal. (c) Adoption of PCC allows the substrate amino terminus
to attack the acyl complex forming a new cyclizing peptide bond. The enzyme-bound AYD signal prevents water from attacking the acyl complex.
Figure 2. Sketch of the BXD method is shown on the left. With conventional MD a simulated trajectory (blue line) will not be able to cross large
free energy barriers so sampling is poor. With BXD, reﬂecting boundaries are placed along the reaction coordinate chosen to describe the process,
splitting the phase space into boxes (n, n+1, n+2···). By restricting the trajectory within a box for a length of time, and then allowing it to pass into
the next box and restricting it there, the boxes act as a thermal ratchet and allow free energy barriers to be crossed. On the right, a plot of the reaction
coordinate value against simulation time from a BXD simulation shows how the trajectory (blue) moves through the boxes and samples the space.
The boxes’ boundaries are shown by vertical lines.
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These sequences were designed to cover the 20 natural amino
acids as well as few unnatural and modiﬁed amino acids. Most
of these sequences were derived from cyanobactin sequences
found in the literature,19 while some others were designed to
study the substrate tolerance of the enzyme. The substrates
were treated with PatGmac under identical conditions (see
Supporting Information for the details), and the reactions were
analyzed by (LC-MS). It was found that 11 out of 25 sequences
were cyclizable. The experimental information was withheld
from our simulation team until predictions had been made,
ensuring blind test conditions.
For all 25 sequences, their probabilities of PCC formation
were calculated, and it was shown that that correlation between
the calculated probability and cyclization indeed exists.
Although some computational studies21−23 of peptide cycliza-
tion have been reported, to the best of the authors’ knowledge,
no predictive model has been rigorously tested against an
experimental data set.
Calculating P(PCC), the probability of the PCC formation
was not a trivial task because the ability of MD to simulate rare
events, characterized by high free energy and long time scales, is
severely limited.3−5,24,25 We have used boxed molecular
dynamics (BXD), a method that overcomes the long time
scale and high free energy problem. Previously BXD has been
successfully employed to simulate a wide range of diﬃcult
processes such as protein unfolding in atomic force microscopy
experiments, nonenzymatic peptide cyclization, and diﬀu-
sion.3−5,24,26
In BXD, a reaction coordinate is deﬁned ﬁrst to describe the
process of interest. Then, BXD places boundaries along the
reaction coordinate, splitting the phase space into boxes. As the
simulation progresses, the value of the reaction coordinate is
monitored. If the trajectory crosses a boundary between two
neighboring boxes, the velocity in the direction of the reaction
coordinate is inverted, conﬁning the trajectory within a box.
After a set amount of time, the trajectory is allowed to proceed
into the next box where it is again conﬁned. In this way the
trajectory cannot roll back downhill into a free energy
minimum; free energy barriers are crossed eﬃciently because
the boxes act as a thermal ratchet as shown below in the Figure
2a. In practice, multiple passage of the boxes are allowed back
and forth in the reaction coordinate as shown by Figure 2b.
For the BXD trajectory shown in Figure 2b, a box-to-box rate
constant can be found simply as the average time between two
subsequent trajectory inversions on the border between the
boxes, using also the decorrelation procedure.4 Decorrelation is
needed to remove the contribution of the inversions that are
separated by a very short time and therefore are not
independent from each other. When all box-to-box rate
constants are determined, it is then possible to construct the
free energy proﬁle along the reaction coordinate for the process
of interest. With BXD it is possible to obtain free energies in
the regions that cannot be reached by standard MD, as well as
detailed kinetics for processes occurring on a time scale as long
as seconds, many orders of magnitude beyond the reach of
conventional MD.
BXD belongs to the class of methods that deal with the long
time scale problem by considering only the motion along a
reaction coordinate and therefore have their origin in the
umbrella sampling.27−29 The advantage of BXD is that it
provides both kinetic and thermodynamic information without
any biasing forces or modiﬁcation of the potential energy
landscape. Another advantage is that it uses very simple
language of the transition state theory familiar to chemists.
BXD relies on a good choice of reaction coordinate, which for
peptide cyclization is chosen naturally as the C and N termini
end-to-end distance. A more detailed description of BXD, along
with many of its applications may be found in the
literature,3−5,24,26 where it is also compared with other similar
techniques.
Results and Discussion. We have used BXD implemented in
CHARMM code30 to simulate the propensity of 25 diﬀerent
peptide substrates to adopt the PCC. The reaction coordinate
was chosen as the distance between C and N termini of the
cyclizing peptide sequence. For each peptide sequence, 20
trajectories similar to the one shown in Figure 3 were run until
converged, usually after 20 to 40 cycles through the reaction
coordinate. The free energy diﬀerence ΔGn−1,n between
the adjacent boxes n−1 and n was then calculated
as the equilibrium constant is related to the rate con-
stants of box-to-box transition calculated by BXD:
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can be found. Then the probability of ﬁnding the peptide in its
PCC can be calculated. Deﬁning the PCC as occurring when
the termini are within 4 Å of each other, the probability of
ﬁnding a peptide in the PCC fold is given as
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where the numerator is the sum of the Boltzmann factors in the
M boxes below 4 Å and the denominator is the sum of the
Boltzmann factors over all N boxes present in the simulation.
The assumption that the C−N bond is formed at the distance
of 4 Å, which is a reasonable estimate for the transition state. In
ref 5, a slightly longer parameter (5 Å) was used because there
the process of “recyclization”, in which the bond is ﬁrst broken
and then recombines, was considered. The kinetics of such
Figure 3. Cyclization free energy proﬁle (PMF) for a typical pair of
sequences tested, showing a peptide that cyclizes readily (18, red) and
one that does not cyclize (17, blue). The 4 Å threshold that deﬁnes the
separation of the termini in the PCC is shown by the gray line. In the
native state of the peptide 18 its termini are close to each other. This is
not the case for the peptide 17, which needs to overcome 20 kJ mol−1
barriers to reach PCC.
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recombination is almost independent of the position of the
transition state.
The peptides were simulated in isolation without the
presence of any enzyme for three reasons:
(1) It is not known to what extent the enzyme assists with
the formation of the PCC (frame c, Figure 1), or if this
step is diﬀusional, i.e., the bound substrate randomly
explores its conformational space and ﬁnds the PCC.
However, if the mechanism described previously is
accurate and the cyclization of a peptide depends on
the free energy of cyclization in the absence of an
enzyme, then the PCC formation step (frame c in Figure
1) is conﬁrmed as the rate-limiting step.
(2) If the predictions are accurate without an enzyme being
simulated then similar predictions can be valid for
nonenzymatic methods of N to C cyclization as well,
making this method even more generally useful.
(3) Without an enzyme, the simulations are signiﬁcantly
faster. This is important if a practical high-throughput in
silico screening tool is to be produced.
As it is not known to what extent the bound substrate is
exposed to water, a low-cost implicit solvent model31 was used
to approximate the eﬀects of real water.
The free energy along the cyclization coordinate was
calculated for each of the 25 peptides. Figure 3 shows the
cyclization free energy proﬁles (PMF) for a peptide that
cyclizes readily (Peptide 18) and one that does not cyclize
(Peptide 17).
The full list of sequences presented along with their
cyclization free energy proﬁles can be found in Table 1 and
in the Supporting Information, which also present experimental
LC-MS data.
BXD ranks the peptides in order of their PCC probability,
whereas the experimental data consists of a binary yes/no on
whether the peptide can be cyclized. Sequences with the
highest PCC probability were predicted to cyclize. The results
of calculating the PCC probability given by eq 1 are shown in
Table 1, which summarizes the predictions of the blind test. To
compare the predictions of BXD with experiment, we have used
additional information that only 11 of the 25 peptide sequences
were found to be cyclizable experimentally and therefore 11
sequences with the highest P(PCC) were predicted to cyclize.
According to Table 1, BXD was correct in 21 out of 25 cases,
giving an accuracy of 84%. Very importantly, all predictions
with a high or a low score were correct, and all mismatches
occurred only for the medium probability P(PCC). This is ideal
for a computational screening tool. When faced with a large set
of candidate sequences, a developer of cyclic peptides could use
the model presented here and be highly conﬁdent that the top
ranked sequences would cyclize, allowing the development to
proceed on these peptides with a high degree of certainty that
the ﬁnal cyclization step is possible. Conversely, there would be
a set of peptides with lower predicted P(PCC) that the
developer would know not to invest any more time in, as it is
Table 1. List of Peptides Tested and Comparison of BXD Prediction with Experimenta
aThe peptides in the table are arranged in the order of descending P(PCC). Substrates were synthesized with an AYDG recognition signal at the C-
terminal of each sequence. This signal is then cleaved by the enzyme before cyclisation occurs. J = Fmoc-L-propargylglycine; Pip = Piperidine; ΨP =
pseudo Proline; Z = Amino alanine; Fmoc = Fmoc protected; TFA = TFA protected; Ac = Acetylated; Amino acids in red are in D conformation.
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highly likely that they can not be cyclized. Thus, even though
the model is not 100% accurate, it could be used to make large
savings in time and cost for a producer of cyclic peptides.
The success of our blind test gives insight into the
mechanism of enzyme-mediated cyclization by suggesting that
the PCC formation, shown in Figure 1c, is indeed the rate-
limiting step. Also the fact that the predictions were accurate
without including any details of the enzyme itself means that
the PCC formation is diﬀusional and occurs with little or no
mechanical assistance from the enzyme. To test whether the
cleavage of the AYD tag (frame b, Figure 1) occurs before or
after the formation of the PCC, additional simulations were
performed:
(1) First, in order to test the hypothesis that PCC could be
formed in solution before binding, we performed
calculations of free energies of all core sequences given
in Table 1 but with the AYD tag attached to them. The
reaction coordinate was still the distance between C and
N termini of the cyclizing core sequence, but the AYD
tag was attached to its C terminus.
(2) Second, we tested the hypothesis that the PCC can also
be formed right after the binding of AYD to the surface
of PatGmac at the stage shown by Figure 1a, before the
cleavage of the AYD tag. To simulate the AYD tag
attached to the surface of the enzyme, CHARMM
dihedral constraints were used, which apply a very large
potential energy penalty to rotation around a dihedral,
preventing the rotation from happening. The constraints
around the dihedrals in the backbone of the AYD tag and
on the backbone bond between the tag and the ﬁrst
residue of the core sequence were applied. For example,
for the sequence X1-X2-A-Y-D, the backbone bonds in
AYD and the peptide bonds between D-Y, Y-A, and A-X2
were restrained, rendering the AYD tag immobile.
Both types of simulation performed very badly, achieving an
accuracy of around 50%, the worst possible score. Thus, our
calculations support the proposed mechanism of cyclization
shown in Figure 1, where PCC is formed after AYD tag being
detached from the cyclizing sequence as shown in Figure 1c. It
also supports the assumption that after forming the acyl
complex the enzyme does not inﬂuence the conformational
dynamics of the core sequence forming PCC and this dynamics
is similar to that in solution. The role of the enzyme is to
protect the acyl complex from water and allow its attack by the
N-terminus amino group. Thus, the success of the reported
blind test sheds light on the mechanism of cyclization by
cyanobactin macrocyclase.
On the practical side, the high accuracy of the predictions in
Table 1 suggests that we have developed a computational tool
that can reliably ﬁnd peptide sequences with high P(PCC) for
cyclization by PatGmac. It also can discard noncyclisable
sequences, characterized by low probability P(PCC). The top
and bottom of Table 1 were predicted correctly, with the
uncertainty occurring only in the middle of Table 1 for medium
probabilities of the PCC formation. As explained above, this is
an important factor in a screening tool, as, when a data set is
presented, the model can make conﬁdent and reliable ﬁndings
of the most and the least favorable sequences. The simplicity
and speed of the model makes it suitable for broad use. As PCC
formation can be one of the stages of cyclization processes
other than by cyanobactin macrocyclase, the developed
computational tool may be of more general use.
Currently more work is under way in our groups.
Experimentally we are focusing on obtaining kinetic informa-
tion on the rate of cyclization as opposed to simply a yes/no
indication of the presence of the cyclic product. Experimental
information about cyclization kinetics would allow ranking
peptides according to their cyclization rate and making a more
thorough comparison of the experimental rank with that of
theoretical calculations given in Table 1.
There are a number of new theoretical tasks on our list. First,
the role of the enzyme needs to be investigated in more detail.
While it seems that the PatGmac enzyme does not actively bring
the ends of the peptide together, it is possible that it oﬀers
some small assistance, which would make the simulation of
isolated peptides less reliable for the peptides in the medium
range of P(PCC) in Table 1. Also, other enzymes that assist
folding may be found in the future. In this case, obtaining
correlation between theory and experiment will require taking
into account the dynamics of enzyme, not just that of the
substrate sequence as has been done here. Second, we are
looking at a large number of new sequences trying to expand
our data set. We also hope that with some optimizations of the
code and the algorithm we will be able to scan peptide
sequences systematically and predict many new cyclizable
peptides. With the help of new improvements of the BXD
algorithm,32 a systematic scan of ALL four or perhaps even ﬁve
residue peptides may be within the reach.
Finalizing this paper, we conclude that even the limited data
set presented in this work provides mechanistic details for
peptide cyclization by PatGmac. A computational technique for
screening peptide sequences and scoring their likelihood to
cyclize has been developed and can be used as a screening tool
for future cyclic peptide production. Our in silico tool requires
only peptide sequences as an input. To the best of the authors’
knowledge, this is the ﬁrst time that peptide cyclization has
been predicted quickly and accurately against an experimental
data set.
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